Clinical trials
Recruiting Phase 1 trials in Hungary
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Semmelweis University | 2 |
| BioNTech SE | 1 |
| Bristol-Myers Squibb | 1 |
| Chugai Pharmaceutical | 1 |
| Duke Street Bio Ltd | 1 |
| Enliven Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatic Insufficiency | 2 |
| Hypoxia-Ischemia, Brain | 2 |
| Antiphospholipid Syndrome | 1 |
| Behcet Syndrome | 1 |
| Brain Injuries | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Dermatomyositis | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid, Chronic-Phase | 1 |
| Multiple Endocrine Neoplasia Type 2a | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.